Search

Search Results for "wet age-related macular degeneration (wet AMD)"

Exploring Treatment Strategies for Wet AMD and DME

High-Dose Aflibercept: Promising Results thumbnail

High-Dose Aflibercept: Promising Results

Lloyd Clark, MD, FASRS

What Is Wet Age-Related Macular Degeneration? thumbnail

What Is Wet Age-Related Macular Degeneration?

A TKI Update for Wet AMD thumbnail

A TKI Update for Wet AMD

Carl D. Regillo, MD and R.V. Paul Chan, MD, MSc, MBA, FACS

Thumbnail for manes

The Pathophysiology of Wet AMD

Genentech, Inc.

Thumbnail for rscis

Gene Therapy for Wet AMD

Szilard Kiss, MD

Thumbnail for orudq

Optimizing Visual Outcomes in Wet AMD

Carl D. Regillo, MD, FACS

Thumbnail for jrtoy

Baseline Features and Treatment Outcomes in Wet AMD

Nathan C. Steinle, MD

Wet AMD and DME Therapy in Development thumbnail

Wet AMD and DME Therapy in Development

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

Why Do Real-World Wet AMD Outcomes Differ From Those Seen in Clinical Trials? thumbnail

Why Do Real-World Wet AMD Outcomes Differ From Those Seen in Clinical Trials?

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

A Treatment Paradigm for Wet AMD thumbnail

A Treatment Paradigm for Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

How Can a Multi-MOA Approach Benefit the Management of Wet AMD? thumbnail

How Can a Multi-MOA Approach Benefit the Management of Wet AMD?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet
AMD thumbnail

Phase 3 Clinical Trial Data for EYLEA HD^® (aflibercept) Injection 8 mg for the Treatment of Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

TKIs: How Do They Work? thumbnail

TKIs: How Do They Work?

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

Patient Selection for EYP-1901 thumbnail

Patient Selection for EYP-1901

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Thumbnail for dbqkfe

A Research Analysis of Brolucizumab in the Real World

Michael S. Ip, MD

How May Tolerance for Subretinal Fluid Change Given Sustained-Release EYP-1901? thumbnail

How May Tolerance for Subretinal Fluid Change Given Sustained-Release EYP-1901?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

What is EYP-1901 (DURAVYU™, (vorolanib intravitreal insert))? thumbnail

What is EYP-1901 (DURAVYU™, (vorolanib intravitreal insert))?

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression thumbnail

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision thumbnail

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

View More